Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) FCF Margin (2022 - 2025)

Envoy Medical's FCF Margin history spans 4 years, with the latest figure at 7744.0% for Q4 2025.

  • Quarterly results put FCF Margin at 7744.0% for Q4 2025, up 310600.0% from a year ago — trailing twelve months through Dec 2025 was 7626.56% (up 78633.0% YoY), and the annual figure for FY2025 was 7626.56%, up 78633.0%.
  • FCF Margin for Q4 2025 was 7744.0% at Envoy Medical, up from 10428.57% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1296.25% in Q3 2023 to a low of 12100.0% in Q4 2022.
  • The 4-year median for FCF Margin is 7927.43% (2025), against an average of 7756.24%.
  • The sharpest move saw FCF Margin skyrocketed 1051222bps in 2023, then crashed -804625bps in 2024.
  • Year by year, FCF Margin stood at 12100.0% in 2022, then rose by 3bps to 11753.68% in 2023, then rose by 8bps to 10850.0% in 2024, then rose by 29bps to 7744.0% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 7744.0%, 10428.57%, and 5719.23% for Q4 2025, Q3 2025, and Q2 2025 respectively.